News

Find updates on the work of our researchers here, as well as news about recent advances in Alzheimer's science, funding and awareness.

Cure Alzheimer's Fund's Dr.Tanzi Briefs Congress on Research Progress, Rep. Markey Praises Fund

Washington – With more than 5 million Americans now living with Alzheimer’s disease, a 10 percent increase since 2002, medical researchers are in a sprint to map and sequence the genes susceptible to Alzheimer’s in hopes of leading to more aggressive therapeutic interventions to slow, stop or even reverse the effects of the disease.

Cure Alzheimer's Fund's Dr. Rudy Tanzi Honored as Top Researcher by the Alzheimer's Association

Washington – In recognition of his groundbreaking genetic research and outstanding leadership and commitment to finding a cure and better treatment for Alzheimer’s disease, Dr. Rudolph Tanzi received the 2007 Ronald and Nancy Reagan Award at the Alzheimer’s Association’s National Gala this week.

Massachusetts General Hospital Honors Cure Alzheimer's Fund with First-Ever Philanthropic Award

Boston – Massachusetts General Hospital (MassGeneral) has honored Cure Alzheimer’s FundTM for its leadership, entrepreneurial philanthropy and investment in research projects that have the highest probability of slowing, stopping or reversing Alzheimer's disease. The first annual Award for “Philanthropic Innovation and Investment” was presented to the Fund by MassGeneral’s Institute for Neurodegenerative Disease, at a ceremony at Massachusetts General Hospital on Friday, March 2.

New Web-based Alzheimer's Disease Genetic Research Clearinghouse Launched

First-of-its-Kind Online Resource (ww.alzgene.org) Offers Researchers an Extensive Database of Studies on the Genes Associated with Alzheimer's Risk

Boston, MA – AlzGene, a web-based clearinghouse for researchers working to unlock the genetic makeup of Alzheimer’s Disease, has been launched as a way to gather and analyze studies by and for investigators around the world. The project aims to bring clarity to the increasingly prolific and confusing field of Alzheimer’s genetics research.

Cure Alzheimer's Fund supported project, AlzGene, published in leading journal

Paper describing the development and function of the AlzGene database of genetic studies in Nature Genetics.  Project is first of its kind.

100 Years of Alzheimer's Disease Discovery November 6, 1906

Fast-Track Research Effort Hopes to Map Genes Affecting Risk for Alzheimer’s Disease within 18 Months

Is A Cure Around the Corner?

Private-Venture Philanthropy Model Changing the Face of Medical Research

BOSTON – On the eve of the 100th anniversary of the discovery of Alzheimer’s disease, medical researchers are in a sprint to map and sequence the genes susceptible to Alzheimer’s, leading to more aggressive therapeutic interventions to slow, stop or even reverse the effects of the disease. It is a race that must be won in the next few years if we are to save up to 16 million baby boomers from the devastation of the disease, says Dr. Rudolph Tanzi, lead researcher for the Cure Alzheimer’s Fund.

World-Renowned Harvard Alzheimer's Doctor Discusses Latest Alzheimer's Research on Martha's Vineyard

Massachusetts to Face 40% Increase in Alzheimer’s Cases by 2050

Dr. Rudolph E. Tanzi, Ph.D., Director of Aging Research, Harvard Medical School Chair of the Cure Alzheimer’s Fund’s Research Consortium

Hyannis Port, Mass. --- Up to 16 million Americans and 350,000 Massachusetts residents could have Alzheimer’s disease by the year 2050 if a prevention or cure is not found during the next few years was the key message of a presentation by Dr. Rudolph E. Tanzi, Director of the Genetics and Aging Research Unit at Massachusetts General Hospital/Harvard Medical School, August 3 at the Martha’s Vineyard home of Jacqui and Jeff Morby, two of the founders of Cure Alzheimer’s fund.

Harvard Alzheimer's Doctor Discusses Latest Research for Finding a Cure for Alzheimer's in Hyannis Port

Massachusetts to Face 40% Increase in Alzheimer’s Cases by 2050

Dr. Rudolph E. Tanzi, Ph.D., Director of Aging Research, Harvard Medical School Chair of the Cure Alzheimer’s Fund’s Research Consortium

Hyannis Port, Mass. --- Up to 16 million Americans and 350,000 Massachusetts residents could have Alzheimer’s disease by the year 2050 if a prevention or cure is not found during the next few years was the key message of a presentation by Dr. Rudolph E. Tanzi, Director of the Genetics and Aging Research Unit at Massachusetts General Hospital/Harvard Medical School, July 31 at the Hyannis Port home of Judy and Rick Brand, friends of Cure Alzheimer’s Fund.

Florida Baby Boomers Face Alzheimer's Epidemic

64% Increase in Cases Expected by 2025

World-Renowned Harvard Alzheimer’s Doctor Discusses Latest Research for Finding a Cure for Alzheimer’s in North Sewall’s Point

North Sewall’s Point, FL --- Up to 16 million Americans could have Alzheimer’s disease by the year 2050 if a prevention or cure is not found during the next few years was the key message of a presentation by Dr. Rudolph E. Tanzi, Director of the Genetics and Aging Research Unit at Massachusetts General Hospital/Harvard Medical School, this past weekend at the North Sewall’s Point home of Phyllis and Jerry Rappaport, one of the founder’s of the Cure Alzheimer’s Fund.

Alzheimer's Research Takes Hit In Bush Budget

HHS spending on Alzheimer's disease would fall from $652 million to $645 million.